Mauli Desai, MD, Allergist & Immunologist, and David Rosenstreich, MD, Professor of Allergy & Immunology, Microbiology & Immunology, and Otorhinolaryngology, for Montefiore Einstein Anyone who’s ever ...
Please provide your email address to receive an email when new articles are posted on . “Asthma care in the Netherlands is divided between different health care providers, including respiratory ...
In patients with moderate-to-severe allergic asthma, tezepelumab yields the greatest reduction in exacerbations among ...
This summer’s family barbecue was supposed to be a celebration of sorts—coming together for the first time since the pandemic pulled the plug on group activities. But your joy was cut short by an ...
The latest advances in asthma care combine revolutionary biologics, individualized immunotherapy, and targeted treatments that address specific triggers, ditching the “one-size-fits-all” approach. The ...
Please provide your email address to receive an email when new articles are posted on . With $31 million in funding from the Patient-Centered Outcomes Research Institute, researchers will investigate ...
MedPage Today on MSN
Regulatory T-Cell Drug Promising for Eczema, With Hint for Asthma as Well
For the primary endpoint, Eczema Area and Severity Index (EASI) improved by 53-61% in a dose-dependent manner across the ...
Hosted on MSN
Afternoon could be best time for asthma inhaler
Scientists have found the optimal time for asthma patients to use inhalers that could reduces their chances of suffering a potentially serious attack. For asthma sufferers using a brown inhaler the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results